Overview
Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis
Status:
Completed
Completed
Trial end date:
2015-10-01
2015-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the present study was to evaluate the effects of subgingival delivery of boric acid gel as an adjunct to scaling and root planing in chronic periodontitis (CP) patients.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Government Dental College and Research Institute, BangaloreTreatments:
Tetrahydrozoline
Criteria
Inclusion Criteria:- Systemically healthy with deep pockets (PD of ≥5mm or CAL ≥4mm) and vertical bone loss
≥3 mm on intraoral periapical radiographs
- Patients with ≥20 teeth with no history of periodontal therapy in the preceding 6
months nor under any antibiotic therapy
Exclusion Criteria:
- Patients on systemic boron therapy
- Known or suspected allergy to boron supplementation
- Patients with aggressive periodontitis
- Tobacco use in any form, smokers, alcoholics
- Immunocompromised and systemically unhealthy patients
- Pregnant or lactating females